Law360, New York (July 02, 2007, 12:00 AM ET) -- The judge overseeing the multidistrict litigation involving controversial antipsychotic drug Zyprexa has shot down Eli Lilly's request for summary judgment, ruling that a set of plaintiffs has a right to pursue its fraud and overpricing claims against the pharmaceutical giant.
On Thursday, Senior U.S. District Judge Jack Weinstein sided against Lilly in a portion of the chaotic litigation, ruling that the group of direct purchasers should be allowed to proceed with their overpayment complaint.
“While the case is close, plaintiffs have sufficiently demonstrated for purposes of...
Lilly Suffers Setback In Zyprexa Suit
To view the full article, take a free trial now.
